Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits
Sign Up to like & getrecommendations! Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-022-06306-4
Abstract: Mpro, the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for the viral life cycle. Accordingly, several groups have performed in silico screens to identify Mpro inhibitors that might be… read more here.
Keywords: sars cov; non covalent; cov mpro; covalent sars ... See more keywords